Vivos Therapeutics Taps AI to Unlock $9M+ in Annual Value at Sleep Centers
VVOS is trading near its 52-week low of $0.302 (6.7% above the low) on light trading volume (0.3× avg).
Summary
Vivos Therapeutics is expanding its partnership with Greenway Health to deploy an AI-driven platform across its clinical and revenue operations, starting with Sleep Centers of Nevada. The company estimates the automation could generate $9.1 million in annual value at that location alone, plus $1.8 million in savings from recovered labor hours. This follows a series of financing moves and a going concern warning — the AI push is a direct attempt to create operating leverage without proportional cost increases. The company also plans to roll out the platform to new sites in Arizona and Florida as it expands. If the projected savings materialize, they could meaningfully improve the cash-burn trajectory that has threatened the company's viability.
At the time of this announcement, VVOS was trading at $0.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.4M. The 52-week trading range was $0.30 to $5.12. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.